[Neonatal infections caused by group B beta-hemolytic Streptococcus].
The aim of the Asiago Congress is to illustrate the progress in Group B Streptococcal neonatal disease management. It is of primary importance the obstetricians and neonatologists should think alike and should not allow their interest to develop along separate lines. The themes of the Congress were the incidence, the clinical and diagnostic new features, the old and the new therapeutic trends and the obstetrician's prevention. Contributions from twenty-four Neonatologist Groups are included; they are summarized in four main articles and all together they form a synopsis of modern clinical practice and recent research in neonatal medicine.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007167:Immunotherapy; D007231:Infant, Newborn; D012307:Risk Factors; D013290:Streptococcal Infections / Q000175:diagnosis / Q000628:therapy; D013292:Streptococcus agalactiae
D000900:Anti-Bacterial Agents; D007136:Immunoglobulins; D016179:Granulocyte Colony-Stimulating Factor
Le infezioni neonatali da streptococco beta-emolitico di gruppo B.